Trial intelligence / Profile preview

Effect of Exjade on Levels in Patients With Thalassemia

IRCT201412097677N3Phase 3Completed

Sponsor
Kermanshah University of Medical Sciences
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of deferasirox in beta thalassemia major, sponsored by Kermanshah University of Medical Sciences. Started May 2014; status: completed.

02

Drugs

deferasirox
03

Conditions

beta thalassemia major

Beyond the preview

Go deeper on IRCT201412097677N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201412097677N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call